ArticleDigital health
Features and characteristics of publicly available mHealth apps for self-management in chronic obstructive pulmonary disease.
Article in Digital health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- The Current Status, Challenges, and Optimization Strategies for Self-Management in Patients with COPD: A Review.International journal of chronic obstructive pulmonary disease · 2026Review
- Five years of app evaluation: Insights from a framework in practice - a systematic review on the m-health index and navigation database.Internet interventions · 2025Article
- An mHealth App and System Architecture for Respiratory Disease Management: Design Principles, Tool Development, and Pilot Usability Study.JMIR formative research · 2025Article
- Mobile Phone Auscultation Accurately Diagnoses Chronic Obstructive Pulmonary Disease Using Nonlinear Respiratory Biofluid Dynamics.Diagnostics (Basel, Switzerland) · 2025Article
- Digital health technologies for improving the management of people with chronic obstructive pulmonary disease.Frontiers in digital health · 2025Review
- Assessment of Medication Adherence Using Mobile Applications in Chronic Obstructive Pulmonary Disease: A Scoping Review.International journal of environmental research and public health · 2024Article
- A mobile-based self-care application for patients with chronic obstructive pulmonary disease: A protocol for design, implementation, and evaluation.Health science reports · 2024Article
- What's Next in MHealth Apps in Rehabilitation: Re-Directing Our Attention to Evaluating Quality.Physiotherapy Canada. Physiotherapie Canada · 2024Article
- Article
- Mobile Apps for Patients with Peritoneal Dialysis: Systematic App Search and Evaluation.Healthcare (Basel, Switzerland) · 2024Article
- Functionality and Usability of mHealth Apps in Patients with Peritoneal Dialysis: A Systematic Review.Healthcare (Basel, Switzerland) · 2024Review
- From illness management to quality of life: rethinking consumer health informatics opportunities for progressive, potentially fatal illnesses.Journal of the American Medical Informatics Association : JAMIA · 2024Article
- Recent Advances in the Devices for the Treatment of Chronic Obstructive Pulmonary Disease: A Review.Cureus · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mobile health applications (mHealth apps) may be able to support people living with chronic obstructive pulmonary disease (COPD) to develop the appropriate skills and routines for adequate self-management. Given the wide variety of publicly available mHealth apps, it is important to be aware of their characteristics to optimize their use and mitigate potential harms. Objective: To report the characteristics and features of publicly available apps for COPD self-management. Methods: MHealth apps designed for patients' COPD self-management were searched in the Google Play and Apple app stores. Two reviewers trialed and assessed the eligible apps using the MHealth Index and Navigation Database framework to describe the characteristics, qualities, and features of mHealth apps across five domains. Results: From the Google Play and Apple stores, thirteen apps were identified and eligible for further evaluation. All thirteen apps were available for Android devices, but only seven were available for Apple devices. Most apps were developed by for-profit organizations (8/13), non-profit organizations (2/13), and unknown developers (3/13). Many apps had privacy policies (9/13), but only three apps described their security systems and two mentioned compliance with local health information and data usage laws. Education was the common app feature; additional features were medication reminders, symptom tracking, journaling, and action planning. None provided clinical evidence to support their use. Conclusions: Publicly available COPD apps vary in their designs, features, and overall quality. These apps lack evidence to support their clinical use and cannot be recommended at this time.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.